"10.1371_journal.pone.0063785","plos one","2013-05-20T00:00:00Z","Katie Matthews; Nancy P Y Chung; Per Johan Klasse; Magda Moutaftsi; Darrick Carter; André M Salazar; Steven G Reed; Rogier W Sanders; John P Moore","Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America; HIV Vaccine Initiative at Bill and Melinda Gates Foundation, Seattle, Washington, United States of America; Infectious Diseases Research Institute (IDRI), Seattle, Washington, United States of America; Oncovir, Inc., Washington D.C., United States of America; Laboratory for Experimental Virology, Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands","Conceived and designed the experiments: KM NPYC MM RWS JPM. Performed the experiments: KM NPYC. Analyzed the data: KM NPYC PJK. Contributed reagents/materials/analysis tools: AMS MM DC SGR. Wrote the paper: KM NPYC DC PJK RWS JPM.","The authors have the following interests. Dr. Andre Salazar is CEO and Scientific Director of Oncovir Inc., a commercial company which provided Hiltonol. Dr. Salazar also holds stock in the company. To clarify, Drs. Steven G. Reed and Darrick Carter from IDRI (a non-profit organization) are inventors on patents covering formulations of GLA. The authors declare that this does not alter the authors’ adherence to all of the PLOS ONE policies on sharing data and materials.","2013","05","Katie Matthews","KM",9,TRUE,5,2,3,6,TRUE,TRUE,FALSE,0,NA,FALSE
